Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference
BRISBANE, Calif., January 08, 2025 -- ( BUSINESS WIRE )-- Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene-editing platform to create potential ...
Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
National Resilience, Inc. (Resilience), a technology-driven biomanufacturing leader dedicated to broadening access to complex medicines, today announced the expansion of its collaboration with Parvus ...